Ranitidine hydrochloride (CAS 66357-59-3)
QUICK LINKS
Ranitidine hydrochloride is a histamine H2-receptor antagonist that functions by competitively inhibiting the action of histamine at the H2 receptors of the parietal cells in the stomach. This inhibition results in a reduction in the volume of gastric secretions, as well as a decrease in the overall concentration of hydrogen ions. By decreasing the production of gastric acid, ranitidine hydrochloride can help to create a less acidic environment. Ranitidine hydrochloride′s mode of action involves binding to the H2 receptors on the basolateral membrane of the parietal cell, which ultimately leads to a decrease in the production of gastric acid. Ranitidine hydrochloride may have a cytoprotective effect on the gastric mucosa, which may contribute to its overall impact on reducing gastric acid secretion. Ranitidine hydrochloride plays a role in modulating the production of gastric acid in experimental applications.
Ranitidine hydrochloride (CAS 66357-59-3) References
- Ranitidine hydrochloride X-ray assay using a neural network. | Agatonovic-Kustrin, S., et al. 2000. J Pharm Biomed Anal. 22: 985-92. PMID: 10857567
- Ranitidine hydrochloride, a polymorphic crystal form. | Hempel, A., et al. 2000. Acta Crystallogr C. 56 (Pt 8): 1048-9. PMID: 10944325
- Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. | Adhikary, A. and Vavia, PR. 2008. Drug Dev Ind Pharm. 34: 860-9. PMID: 18618306
- Quantification of ranitidine hydrochloride in the presence of its decomposition product by spectrophotometric methods. Application for kinetic study. | Sokół, A., et al. 2011. Acta Pol Pharm. 68: 169-77. PMID: 21485289
- Ranitidine Hydrochloride-loaded Ethyl Cellulose and Eudragit RS 100 Buoyant Microspheres: Effect of pH Modifiers. | Kotagale, NR., et al. 2011. Indian J Pharm Sci. 73: 626-33. PMID: 23112396
- Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration. | Inagaki, K., et al. 2000. Int J Pharm Compd. 4: 150-3. PMID: 23985950
- Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage forms--an exercise in method selection, development, definition and validation. | Evans, MB., et al. 1989. J Pharm Biomed Anal. 7: 1-22. PMID: 2488600
- Discrimination of ranitidine hydrochloride crystals using X-ray micro-computed tomography for the evaluation of three-dimensional spatial distribution in solid dosage forms. | Yamamoto, E., et al. 2021. Int J Pharm. 605: 120834. PMID: 34192587
- N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride. | Yokoo, H., et al. 2021. Chem Pharm Bull (Tokyo). 69: 872-876. PMID: 34470951
- Ultrasensitive Functionalized Polymeric-Nanometal Oxide Sensors for Potentiometric Determination of Ranitidine Hydrochloride. | Alshehri, EM., et al. 2022. Polymers (Basel). 14: PMID: 36236096
- Ranitidine hydrochloride-induced hypergastrinemia. | Chisholm, JC. 1985. J Natl Med Assoc. 77: 303-4. PMID: 3999148
- Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration. | Burm, JP., et al. 1994. Am J Hosp Pharm. 51: 1201-4. PMID: 7913797
- The safety of ranitidine in over a decade of use. | Mills, JG., et al. 1997. Aliment Pharmacol Ther. 11: 129-37. PMID: 9042985
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Ranitidine hydrochloride, 1 g | sc-204874 | 1 g | $33.00 |